Accurately Analyze Metal-Sensitive Compounds with Restek’s New Inert LC Columns
Restek’s new inert LC column technology helps labs improve their analysis of metal-sensitive compounds. A premium inert coating applied to the stainless-steel surface of Restek’s LC columns reduces nonspecific binding of chelating analytes, enabling sensitive analysis and smooth integration of peaks. Combined with Restek’s selective stationary phases, these new inert LC columns are ideal for the analysis of metal-sensitive compounds, such as mycotoxins and organophosphorus pesticides.
Restek's inert LC columns can provide four key benefits:
- Improved peak shape without passivation or mobile phase additives.
- Increased response and analyte recovery, allowing lower detection limits.
- High accuracy and throughput with less variability.
- Less time-consuming conditioning and complicated passivation required.
Restek’s inert LC column technology is available on three column types: Raptor Biphenyl, Raptor ARC-18, and Force Biphenyl. These new columns help bring the benefits of inert technology to labs specializing in small molecule LC-MS/MS workflows.
Learn more at: www.restek.com
Restek Corporation
1-814-353-1300, ext. 3
RAFA 2024 Highlights: Contemporary Food Contamination Analysis Using Chromatography
November 18th 2024A series of lectures focusing on emerging analytical techniques used to analyse food contamination took place on Wednesday 6 November 2024 at RAFA 2024 in Prague, Czech Republic. The session included new approaches for analysing per- and polyfluoroalkyl substances (PFAS), polychlorinated alkanes (PCAS), Mineral Oil Hydrocarbons (MOH), and short- and medium-chain chlorinated paraffins (SCCPs and MCCPs).
Advancing Bladder Cancer Research with Mass Spectrometry: A FeMS Interview with Marta Relvas-Santos
November 12th 2024LCGC International interviewed FeMS Empowerment Award winner Marta Relvas-Santos on her use of mass spectrometry to identify potential biomarkers and therapies for bladder cancer. She also shared insights on her work with FeMS and advice for fellow scientists.
